Acceptability of Fortified Bouillon Cubes in Northern Ghana
NCT ID: NCT05177614
Last Updated: 2022-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2021-11-23
2022-01-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Household Use of Multiple Micronutrient-fortified Bouillon on Micronutrient Status Among Women and Children in Two Districts in the Northern Region of Ghana
NCT05178407
Nutritional Status and Bouillon Use in Northern Ghana
NCT04632771
Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants
NCT03181178
The Effect of Micronutrient Supplementation on Nutrition Status and Well-being
NCT07031973
Efficacy of a Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement for Children Under Two in Cambodia
NCT02257762
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives: This study aims (1) to evaluate the acceptability of bouillon cubes formulated with 6 micronutrients for which deficiency is common among women and children in Ghana and (2) to access the feasibility and reliability of data collection methods to be used in a later study of the effects of fortified bouillon, compared to control, on micronutrient status, health, and development.
Methods: This acceptability study will be conducted in the Kumbungu and Tolon districts in the Northern Region, where a recent survey showed that micronutrient deficiencies were common. The investigators will recruit non-pregnant adult women (15+ years old) (n = 84) who are responsible for household meal preparation, to participate in sensory testing of an uncooked fortified bouillon as well as a cooked food containing the fortified bouillon. Subsequently, participants will receive a 14-day supply of fortified bouillon cubes to use at home, after which they will be asked their opinions about the bouillon. Three fortified bouillon formulations will be tested: 1) upper-level bouillon, fortified with iron, zinc, iodine, vitamin A, folic acid, and vitamin B-12, 2) lower-level bouillon, containing the same 6 micronutrients but with lower concentrations of some micronutrients, and 3) a control bouillon, fortified with iodine only. Participants will be in the study for approximately 18 days (study day 0 to study day 17). In addition, children 2-6 years of age in households of enrolled women will be eligible to participate in a pilot study to evaluate the feasibility and test-retest reliability of several methods to assess child development. For these children, child development will be assessed at two home visits during the 14-day period of fortified bouillon use at home.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Upper-level multiple micronutrient-fortified bouillon cube
10 gram shrimp-flavoured bouillon cube, consumed ad-lib, fortified with six micronutrients
Upper-level multiple micronutrient-fortified bouillon cube
80 µg/g Folic acid 1.2 µg/g Vitamin B12 3 mg/g Zinc (ZnO) 4 mg/g Iron (FePP/citric acid/trisodium citrate) 200 µg/g Vitamin A (retinyl palmitate) 30 µg/g Iodine (KIO3)
Lower-level multiple micronutrient-fortified bouillon cube
10 gram shrimp-flavoured bouillon cube, consumed ad-lib, fortified with six micronutrients
Lower-level multiple micronutrient-fortified bouillon cube
28.8 µg/g Folic acid 0.288 µg/g Vitamin B12 1.68 mg/g Zinc (ZnO) 1.3 mg/g Iron (FePP/citric acid/trisodium citrate) 96 µg/g Vitamin A (retinyl palmitate) 30 µg/g Iodine (KIO3)
Control (iodine-fortified bouillon cube)
10 gram shrimp-flavoured bouillon cube, consumed ad-lib, fortified with one micronutrient
Iodine-fortified bouillon cube
30 µg/g Iodine (KIO3)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Upper-level multiple micronutrient-fortified bouillon cube
80 µg/g Folic acid 1.2 µg/g Vitamin B12 3 mg/g Zinc (ZnO) 4 mg/g Iron (FePP/citric acid/trisodium citrate) 200 µg/g Vitamin A (retinyl palmitate) 30 µg/g Iodine (KIO3)
Lower-level multiple micronutrient-fortified bouillon cube
28.8 µg/g Folic acid 0.288 µg/g Vitamin B12 1.68 mg/g Zinc (ZnO) 1.3 mg/g Iron (FePP/citric acid/trisodium citrate) 96 µg/g Vitamin A (retinyl palmitate) 30 µg/g Iodine (KIO3)
Iodine-fortified bouillon cube
30 µg/g Iodine (KIO3)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* self-reported non-pregnant adult women (15+ years)
* responsible for meal preparation in the household
* signed the informed consent form
Child development assessment pilot sub-study:
* 2-6 years of age (24-71 months)
* residing in the same household as an enrolled woman
* child's primary caregiver signs the informed consent form
Exclusion Criteria
* COVID-19 exposure, positive test, or current symptoms (including fever, cough, shortness of breath, loss of smell, vomiting, or diarrhea \[\> 3 liquid or semi-liquid stools in 24h\]) of illness
* chronic severe medical condition (e.g. malignancy) or congenital anomalies requiring frequent medical attention or potentially interfering with nutritional status or affecting child development (children only)
* presence of ailments (such as toothache, or mouth pain) that may impact a participant's ability to complete study activities (women only)
* unable to provide informed consent due to impaired decision making abilities
* current participation in a clinical trial
* reported shrimp, wheat, milk, soy, eggs, celery, fish, or mollusc allergy, or a previous adverse reaction to bouillon by anyone in the household
* refusal to use provided bouillon cubes to prepare household meals while enrolled in the study
2 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ghana
OTHER
Helen Keller International
OTHER
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Reina Engle-Stone, Ph.D
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reina Engle-Stone, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Seth Adu-Afarwuah, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Ghana
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Ghana
Accra, , Ghana
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wessells KR, Kumordzie SM, Becher E, Davis JN, Nyaaba KW, Zyba SJ, Arnold CD, Tan X, Vosti SA, Adams KP, Haskell M, Adu-Afarwuah S, Engle-Stone R. Acceptability of Multiple Micronutrient-Fortified Bouillon Cubes among Women and Their Households in 2 Districts in The Northern Region of Ghana. Curr Dev Nutr. 2023 Dec 8;8(1):102056. doi: 10.1016/j.cdnut.2023.102056. eCollection 2024 Jan.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
017/12/20
Identifier Type: OTHER
Identifier Source: secondary_id
1687671
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.